Industry Symposium

ALECENSA: The First and Only Adjuvant Treatment for Patients with Resectable ALK + NSCLC

Industry Speaker(s)

• 

  Mark Socinski, MD

  Executive Director (Thoracic Cancer), Medical Oncologist
  Advent Health | Cancer Institute
  Orlando, Florida, United States

  I do not have any relevant financial / non-financial relationships with any proprietary interests..